MSFT P/E of 22 is at the bottom of its 10-year range; stock has returned 0% since Jan 2024 while peers surged 58–158%. High CapEx on Azure/OpenAI is a long-term growth driver. Extreme relative underperformance and depressed valuation create a mean-reversion opportunity as Azure revenue and AI adoption accelerate. Author is buying LEAPS repeatedly, betting that current pricing ignores durable competitive advantages and future earnings growth. Broader market correction (commenter warns of 7–10% drawdown taking MSFT to 300–320); CapEx overshoot if Azure growth disappoints; regulatory or competitive pressure on OpenAI relationship.
MSFT P/E of 22 is at the bottom of its 10-year range; stock has returned 0% since Jan 2024 while peers surged 58–158%. High CapEx on Azure/OpenAI is a long-term growth driver. Extreme relative underperformance and depressed valuation create a mean-reversion opportunity as Azure revenue and AI adoption accelerate. Author is buying LEAPS repeatedly, betting that current pricing ignores durable competitive advantages and future earnings growth. Broader market correction (commenter warns of 7–10% drawdown taking MSFT to 300–320); CapEx overshoot if Azure growth disappoints; regulatory or competitive pressure on OpenAI relationship.